Statins: a repurposed drug to fight cancer

W Jiang, JW Hu, XR He, WL Jin, XY He - Journal of Experimental & …, 2021 - Springer
As competitive HMG-CoA reductase (HMGCR) inhibitors, statins not only reduce cholesterol
and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of …

[PDF][PDF] Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases

Y Song, J Liu, K Zhao, L Gao, J Zhao - Cell metabolism, 2021 - cell.com
High levels of cholesterol are generally considered to be associated with atherosclerosis. In
the past two decades, however, a number of studies have shown that excess cholesterol …

Association of statin use with risk of liver disease, hepatocellular carcinoma, and liver-related mortality

MS Vell, R Loomba, A Krishnan… - JAMA Network …, 2023 - jamanetwork.com
Importance Given the burden of chronic liver disease on the health care system, more
information on the hepatoprotective association of statins in the general population is …

Synergistic hypolipidemic effects and mechanisms of phytochemicals: a review

Y Liu, C Liu, X Kou, Y Wang, Y Yu, N Zhen, J Jiang… - Foods, 2022 - mdpi.com
Hyperlipidemia, a chronic disorder of abnormal lipid metabolism, can induce obesity,
diabetes, and cardiovascular and cerebrovascular diseases such as coronary heart disease …

[HTML][HTML] Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities

EOJ Porta, K Kalesh, PG Steel - Frontiers in Pharmacology, 2023 - frontiersin.org
Chagas disease is a vector-borne illness caused by the protozoan parasite Trypanosoma
cruzi (T. cruzi). It poses a significant public health burden, particularly in the poorest regions …

Effect of statins on lung cancer molecular pathways: A possible therapeutic role

G Marcianò, C Palleria, A Casarella, V Rania, E Basile… - Pharmaceuticals, 2022 - mdpi.com
Lung cancer is a common neoplasm, usually treated through chemotherapy, radiotherapy
and/or surgery. Both clinical and experimental studies on cancer cells suggest that some …

Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast …

RM Zaki, A El Sayeh Abou El Ela, AS Almurshedi… - Polymers, 2023 - mdpi.com
Various factors limit the use of simvastatin as an anticancer drug. Therefore, this study aimed
to analyse simvastatin (SIM)-loaded cubosome efficacy against breast cancer. SIM-loaded …

Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles

L Bai, Y Wang, J Huo, S Li, Y Wen, Q Liu, J Yang… - Cell Death & …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease caused by
motoneuron loss, for which there is currently no effective treatment. Statins, as inhibitors of 3 …

[PDF][PDF]  The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study

HA Al-hussaniy, AH Al-Shammari, HN Sameer… - …, 2023 - pharmacia.pensoft.net
Background: Statins have emerged as a vital therapeutic option for dyslipidemia, effectively
reducing morbidity and mortality in individuals with various medical conditions. Recent …

PPARα-selective antagonist GW6471 inhibits cell growth in breast cancer stem cells inducing energy imbalance and metabolic stress

V Castelli, M Catanesi, M Alfonsetti, C Laezza… - Biomedicines, 2021 - mdpi.com
Breast cancer is the most frequent cancer and the second leading cause of death among
women. Triple-negative breast cancer is the most aggressive subtype of breast cancer and …